Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 41 of 158 for:    Diseases | ( Map: Costa Rica )

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings (DISCOVER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02322762
Recruitment Status : Active, not recruiting
First Posted : December 23, 2014
Last Update Posted : July 26, 2019
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

Brief Summary:
DISCOVER is a Non Interventional Study study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment.

Condition or disease
Type 2 Diabetes Mellitus

Detailed Description:
DISCOVER is a NIS study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment. This study is a multi-country, multicenter, observational, prospective, longitudinal cohort study. The patients will be recruitted from countries in Latin America, Europe and Asia pac. It is estimated that approximately 13350 patients will be enrolled in total with each patient followed up for 3 years.

Layout table for study information
Study Type : Observational
Actual Enrollment : 14173 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings
Actual Study Start Date : December 30, 2014
Estimated Primary Completion Date : August 30, 2019
Estimated Study Completion Date : August 30, 2019

Resource links provided by the National Library of Medicine


Group/Cohort
One single cohort.
One single cohort of patients with type 2 diabetes mellitus initiating their second line anti-diabetic therapy after first line anti-diabetic therapy.



Primary Outcome Measures :
  1. Anti-diabetic treatments prescribed by physicians in a real-world setting. [ Time Frame: Up to 3 Years ]
    The drugs (or their combinations) prescribed by physicians to patients initiating a 2nd line anti-diabetic treatment in a real-world setting will be described at inclusion and during 3 years follow-up.


Secondary Outcome Measures :
  1. Disease control in terms of achieving HbA1c target goals and reducing body weight and blood pressure. [ Time Frame: Up to 3 years ]
  2. Changes in anti-diabetic treatments [ Time Frame: Up to 3 years ]
  3. Disease progression (incidence of microvascular and macrovascular complications). [ Time Frame: Up to 3 years ]
  4. Incidence of hypoglycemic events. [ Time Frame: Up to 3 years ]
  5. Quality of Life, using Patient Reported Outcomes questionnaires. [ Time Frame: Up to 3 years ]
  6. Use of Healthcare resources. [ Time Frame: Up to 3 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with type 2 diabetes mellitus initiating their second line anti-diabetic therapy after first line anti-diabetic therapy. Participating investigators will belong to primary, secondary or tertiary care clinics or hospitals in proportions trying to resemble the reality of management of this type of patients in each country.
Criteria

Inclusion Criteria:

  1. Provision of subject informed consent
  2. Female or male aged 18 years and over
  3. Diagnosed with type 2 diabetes mellitus
  4. Initiating a second line anti-diabetic therapy, either as add-on, or switching from one monotherapy to another.

Exclusion Criteria:

  1. Diagnosis of type 1 diabetes mellitus
  2. Patient is pregnant
  3. Patients initiating a dual therapy after having previously received two different lines of monotherapy before (e.g.: Metformin → SU (Sulphonylureas) → SU+Add-on)
  4. Current treatment with chemotherapy, oral or iv steroids
  5. Patient is on dialysis or has had a renal transplant
  6. The patient is taking insulin as first line treatment
  7. The patient is taking dual therapy or a fixed dose combination treatment as first line treatment.
  8. The patient is taking herbal remedies / natural medicines as first line treatment
  9. Participation in an interventional trial
  10. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient for 3 years (e.g. lifethreatening co-morbidities, tourist, non-native speaker or does not understand the local language where interpreter services are not reliably available, psychiatric disturbances, dementia, alcohol or drug abuse).
  11. Not willing to sign the informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02322762


  Hide Study Locations
Locations
Layout table for location information
Algeria
Research Site
Alger, Algeria
Research Site
Algiers, Algeria
Research Site
Batna, Algeria
Research Site
Blida, Algeria
Research Site
Constantine, Algeria
Research Site
Oran, Algeria
Research Site
Setif, Algeria
Argentina
Research Site
Chacabuco, Argentina
Research Site
Ciudad Autonoma Buenos Aires, Argentina
Research Site
Ciudad Autonoma de Buenos Aires, Argentina
Research Site
Cordoba, Argentina
Research Site
Corrientes, Argentina
Research Site
Parana, Argentina
Research Site
Rosario, Argentina
Research Site
San Miguel de Tucuman, Argentina
Research Site
Santa Fe, Argentina
Australia
Research Site
Blacktown, Australia
Research Site
Broadmeadows, Australia
Research Site
Burwood, Australia
Research Site
Castle Hill, Australia
Research Site
Coorparoo, Australia
Research Site
Corio, Australia
Research Site
Cowra, Australia
Research Site
Edmonton, Australia
Research Site
Forbes, Australia
Research Site
Garran, Australia
Research Site
Ipswich, Australia
Research Site
Melbourne, Australia
Research Site
Mulgrave, Australia
Research Site
Sherwood, Australia
Research Site
Smithfield, Australia
Research Site
South Lake, Australia
Austria
Research Site
Feldbach, Austria
Research Site
Graz, Austria
Research Site
Innsbruck, Austria
Research Site
Linz, Austria
Research Site
Saint Stefan Ob Stainz, Austria
Research Site
Salzburg, Austria
Research Site
St.Veit im Pongau, Austria
Research Site
Vienna, Austria
Research Site
Wien, Austria
Bahrain
Research Site
Bahrain, Bahrain
Brazil
Research Site
Belo Horizonte, Brazil
Research Site
Brasilia, Brazil
Research Site
Campina Grande do Sul, Brazil
Research Site
Campinas, Brazil
Research Site
Caxias do Sul, Brazil
Research Site
Curitiba, Brazil
Research Site
Fortaleza, Brazil
Research Site
Goiania, Brazil
Research Site
Juiz De For A, Brazil
Research Site
Niteroi, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Rio de Janeiro, Brazil
Research Site
Santa Maria, Brazil
Research Site
Sao Jose do Rio Preto, Brazil
Research Site
Sao Jose dos Campos, Brazil
Research Site
Sao Paulo, Brazil
China
Research Site
Beijing, China
Research Site
Changsha, China
Research Site
Chengdu, China
Research Site
Chenzhou, China
Research Site
Chongqing, China
Research Site
Fuzhou, China
Research Site
Guangzhou, China
Research Site
Guiyang, China
Research Site
Hangzhou, China
Research Site
Hefei, China
Research Site
Kunming, China
Research Site
Lanzhou, China
Research Site
Nanjing, China
Research Site
Qingdao, China
Research Site
Shanghai, China
Research Site
Shantou, China
Research Site
Shengyang, China
Research Site
Shijiazhuang, China
Research Site
Suzhou City, China
Research Site
Tianjin, China
Research Site
Wuhan, China
Research Site
Wulumuqi, China
Research Site
Wuxi, China
Research Site
Xi'an, Shaanxi Province, China
Colombia
Research Site
Barranquilla, Colombia
Research Site
Bogota, Colombia
Research Site
Cali, Colombia
Research Site
Manizales, Colombia
Research Site
Medellin, Colombia
Costa Rica
Research Site
Cartago, Costa Rica
Research Site
Heredia, Costa Rica
Research Site
San Jose, Costa Rica
Czechia
Research Site
Benatky nad Jizerou, Czechia
Research Site
Beroun, Czechia
Research Site
Broumov, Czechia
Research Site
Karlovy Vary, Czechia
Research Site
Krnov, Czechia
Research Site
Litomerice, Czechia
Research Site
Nachod, Czechia
Research Site
Olomouc, Czechia
Research Site
Ostrava, Czechia
Research Site
Plzen, Czechia
Research Site
Praha 1, Czechia
Research Site
Praha 8, Czechia
Research Site
Praha, Czechia
Research Site
Uherske Hradiste, Czechia
Research Site
Ujezd U Brna, Czechia
Denmark
Research Site
Hovedstaden, Denmark
Research Site
Jylland, Denmark
Research Site
Midtjylland, Denmark
Research Site
Sjalland, Denmark
Egypt
Research Site
Alexandria, Egypt
Research Site
Asiut, Egypt
Research Site
Banha, Egypt
Research Site
Cairo, Egypt
Research Site
Giza, Egypt
Research Site
Mansoura, Egypt
Research Site
Menyia, Egypt
Research Site
Sheraton Heliopolis, Egypt
Research Site
Souhag, Egypt
Research Site
Tanta, Egypt
Research Site
Zagazig, Egypt
France
Research Site
Alsace, France
Research Site
Aquitaine, France
Research Site
Auvergne, France
Research Site
Basse-Normandie, France
Research Site
Bourgogne, France
Research Site
Bretagne, France
Research Site
Centre, France
Research Site
Champagne-Ardenne, France
Research Site
Franche-Comte, France
Research Site
Haute-Normandie, France
Research Site
Ile-de-France, France
Research Site
Languedoc-Roussillon, France
Research Site
Limousin, France
Research Site
Lorraine, France
Research Site
Midi-Pyrenees, France
Research Site
Nord-Pas-de-Calais, France
Research Site
Pays De La Loire, France
Research Site
Picardie, France
Research Site
Poitou-Charentes, France
Research Site
Provence-Alpes-Cote d'Azur, France
Research Site
Rhone-Alpes, France
India
Research Site
Bangalore, India
Research Site
Belgaum, India
Research Site
Chandigarh, India
Research Site
Chennai, India
Research Site
Coimbatore, India
Research Site
Ghaziabad, India
Research Site
Gurgaon, India
Research Site
Hyderabad, India
Research Site
Indore, India
Research Site
Kanpur, India
Research Site
Karnal, India
Research Site
Kolkata, India
Research Site
Ludhiana, India
Research Site
Mangalore, India
Research Site
Mumbai, India
Research Site
Noida, India
Research Site
Pune, India
Indonesia
Research Site
Balikpapan, Indonesia
Research Site
Banda Aceh, Indonesia
Research Site
Bandung, Indonesia
Research Site
Batu, Indonesia
Research Site
Bekasi Timur, Indonesia
Research Site
Denpasar, Indonesia
Research Site
Jakarta, Indonesia
Research Site
Malang, Indonesia
Research Site
Manado, Indonesia
Research Site
Padang, Indonesia
Italy
Research Site
Foggia, Italy
Research Site
Garbagnate Milanese, Italy
Research Site
Livorno, Italy
Research Site
Mariano Comense, Italy
Research Site
Parma, Italy
Research Site
Pavia, Italy
Research Site
Pisa, Italy
Research Site
Potenza, Italy
Research Site
Rimini, Italy
Research Site
Roma, Italy
Research Site
Sesto San Giovanni, Italy
Jordan
Research Site
Amman, Jordan
Research Site
Az Zarqaa, Jordan
Research Site
Irbid, Jordan
Korea, Republic of
Research Site
Bucheon-si, Korea, Republic of
Research Site
Cheonan-si, Korea, Republic of
Research Site
Chuncheon-si, Korea, Republic of
Research Site
Daejeon, Korea, Republic of
Research Site
Goyang-si, Korea, Republic of
Research Site
Gwangmyeong-si, Korea, Republic of
Research Site
Jeju Special Self-Governing Province, Korea, Republic of
Research Site
Jeollabuk-do, Korea, Republic of
Research Site
Seongnam-si, Korea, Republic of
Research Site
Seoul, Korea, Republic of
Kuwait
Research Site
Kuwait City, Kuwait
Lebanon
Research Site
Beirut Central District, Lebanon
Research Site
Beirut, Lebanon
Research Site
Hamra, Lebanon
Research Site
Jbeil, Lebanon
Research Site
Mazraat Yachouh, Lebanon
Research Site
Periphery, Lebanon
Research Site
Saida, Lebanon
Research Site
Tripoli, Lebanon
Malaysia
Research Site
Air Itam, Malaysia
Research Site
Ipoh, Malaysia
Research Site
Johor Bahru, Malaysia
Research Site
Kelantan, Malaysia
Research Site
Kuala Krai, Malaysia
Research Site
Kuala Lumpur, Malaysia
Research Site
Miri, Malaysia
Research Site
Perak, Malaysia
Research Site
Petaling Jaya, Malaysia
Research Site
Sandakan, Malaysia
Research Site
Seremban, Malaysia
Research Site
Tampin, Malaysia
Mexico
Research Site
Acapulco de Juarez, Mexico
Research Site
Aguascalientes, Mexico
Research Site
Chihuahua, Mexico
Research Site
Guadalajara, Mexico
Research Site
Mexico, Mexico
Research Site
Monterrey, Mexico
Research Site
Queretaro, Mexico
Research Site
San Juan del Rio, Mexico
Research Site
Tamaulipas, Mexico
Research Site
Zapopan, Mexico
Netherlands
Research Site
Almelo, Netherlands
Research Site
Alphen A/d Rijn, Netherlands
Research Site
Amersfoort, Netherlands
Research Site
Amsterdam, Netherlands
Research Site
Bodegraven, Netherlands
Research Site
De Bilt, Netherlands
Research Site
Den Haag, Netherlands
Research Site
Deurne, Netherlands
Research Site
Doetinchem, Netherlands
Research Site
Dordrecht, Netherlands
Research Site
Dorst, Netherlands
Research Site
Drunen, Netherlands
Research Site
Elst, Netherlands
Research Site
Enschede, Netherlands
Research Site
Etten-Leur, Netherlands
Research Site
Garderen, Netherlands
Research Site
Geleen, Netherlands
Research Site
Gouda, Netherlands
Research Site
Heeten, Netherlands
Research Site
Hilvarenbeek, Netherlands
Research Site
Hoogezand, Netherlands
Research Site
Katwijk, Netherlands
Research Site
Kerkrade, Netherlands
Research Site
Kloosterhaar, Netherlands
Research Site
Landgraaf, Netherlands
Research Site
Luttenberg, Netherlands
Research Site
Nieuw Amsterdam, Netherlands
Research Site
Nijverdal, Netherlands
Research Site
Oisterwijk, Netherlands
Research Site
Poortvliet, Netherlands
Research Site
Roermond, Netherlands
Research Site
Soerendonk, Netherlands
Research Site
Steenbergen, Netherlands
Research Site
Stein, Netherlands
Research Site
Utrecht, Netherlands
Research Site
Vaassen, Netherlands
Research Site
Voerendaal, Netherlands
Research Site
Wamel, Netherlands
Research Site
Warffum, Netherlands
Research Site
Wildervank, Netherlands
Research Site
Wouw, Netherlands
Research Site
Zoetermeer, Netherlands
Research Site
Zundert, Netherlands
Norway
Research Site
Akershus, Norway
Research Site
Finnmark, Norway
Research Site
Hedmark, Norway
Research Site
More Og Romsdal, Norway
Research Site
Nord-Trondelag, Norway
Research Site
Nordland, Norway
Research Site
Oslo, Norway
Research Site
Rogaland, Norway
Research Site
Telemark, Norway
Research Site
Vestfold, Norway
Oman
Research Site
Muscat, Oman
Panama
Research Site
Cocle, Panama
Research Site
Panama, Panama
Poland
Research Site
Chorzow, Poland
Research Site
Elblag, Poland
Research Site
Gdansk, Poland
Research Site
Katowice, Poland
Research Site
Kielce, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Lublin, Poland
Research Site
Parczew, Poland
Research Site
Rzeszow, Poland
Research Site
Zabrze, Poland
Research Site
Zgierz, Poland
Russian Federation
Research Site
Arkhangelsk, Russian Federation
Research Site
Barnaul, Russian Federation
Research Site
Moscow, Russian Federation
Research Site
Nizhniy Novgorod, Russian Federation
Research Site
Novosibirsk, Russian Federation
Research Site
Rostov-on-Don, Russian Federation
Research Site
Saint-Petersburg, Russian Federation
Research Site
Saratov, Russian Federation
Research Site
Stavropol, Russian Federation
Research Site
Yaroslavl, Russian Federation
Saudi Arabia
Research Site
Abha, Saudi Arabia
Research Site
Al Jouf, Saudi Arabia
Research Site
Jeddah, Saudi Arabia
Research Site
Khamis Mushayt, Saudi Arabia
Research Site
Riyadh, Saudi Arabia
Research Site
Taif, Saudi Arabia
South Africa
Research Site
Alberton, South Africa
Research Site
Cape Town, South Africa
Research Site
Durban, South Africa
Research Site
Johannesburg, South Africa
Research Site
Lenasia, South Africa
Research Site
Merebank, South Africa
Research Site
Moloto, South Africa
Research Site
Port Elizabeth, South Africa
Research Site
Pretoria, South Africa
Research Site
Umkomaas, South Africa
Spain
Research Site
Alcorcon, Spain
Research Site
Barcelona, Spain
Research Site
Cadiz, Spain
Research Site
Elche, Spain
Research Site
Espinardo, Spain
Research Site
Fuenlabrada, Spain
Research Site
Madrid, Spain
Research Site
Mostoles, Spain
Research Site
Oviedo, Spain
Research Site
Salamanca, Spain
Research Site
Sanlucar de Barrameda, Spain
Research Site
Segovia, Spain
Research Site
Sevilla, Spain
Research Site
Valencia, Spain
Sweden
Research Site
Dalarna, Sweden
Research Site
Jonkoping, Sweden
Research Site
Skane, Sweden
Research Site
Sodermanland, Sweden
Research Site
Stockholm, Sweden
Research Site
Uppland, Sweden
Research Site
Uppsala, Sweden
Research Site
Vasternorrland, Sweden
Taiwan
Research Site
Changhua, Taiwan
Research Site
Kaohsiung, Taiwan
Research Site
New Taipei City, Taiwan
Research Site
Taichung, Taiwan
Research Site
Tainan City, Taiwan
Research Site
Tainan, Taiwan
Research Site
Taipei, Taiwan
Tunisia
Research Site
Gabes, Tunisia
Research Site
Kairouan, Tunisia
Research Site
Mehdia, Tunisia
Research Site
Nabeul, Tunisia
Research Site
Sfax, Tunisia
Research Site
Sousse, Tunisia
Research Site
Tunis, Tunisia
Turkey
Research Site
Adana, Turkey
Research Site
Afyon, Turkey
Research Site
Antalya, Turkey
Research Site
Canakkale, Turkey
Research Site
Corum, Turkey
Research Site
Denizli, Turkey
Research Site
Diyarbakir, Turkey
Research Site
Duzce, Turkey
Research Site
Elazig, Turkey
Research Site
Gaziantep, Turkey
Research Site
Hatay, Turkey
Research Site
Istanbul, Turkey
Research Site
Izmir, Turkey
Research Site
Karaman, Turkey
Research Site
Kayseri, Turkey
Research Site
Samsun, Turkey
United Arab Emirates
Research Site
Abu Dhabi, United Arab Emirates
Research Site
Dubai, United Arab Emirates
Sponsors and Collaborators
AstraZeneca
Investigators
Layout table for investigator information
Study Director: Jesus Medina, PhD AstraZeneca
Principal Investigator: Linong Ji, MD Peking University People's Hospital, China
Principal Investigator: Bong Soo Cha, Dr. Severance Hospital, Yonsei University Health System

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT02322762     History of Changes
Other Study ID Numbers: D1690R00002
First Posted: December 23, 2014    Key Record Dates
Last Update Posted: July 26, 2019
Last Verified: July 2019
Keywords provided by AstraZeneca:
Type 2 diabetes mellitus
Anti-diabetic management patterns
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hypoglycemic Agents
Physiological Effects of Drugs